May 14, 2021
RegMed Investors’ (RMi) closing bell: back on the upside ridge
May 13, 2021
RegMed Investors’ (RMi) closing bell: Dow, S&P and Nasdaq rebound as cell and gene therapy sector tanks again
May 12, 2021
RegMed Investors’ (RMi) closing bell: sector strikes out on fear as the VIX pops +26.33%
May 11, 2021
RegMed Investors’ (RMi) closing bell: the oversold got recognized as dips got bought
May 7, 2021
RegMed Investors’ (RMi) closing bell: earnings related advances
May 6, 2021
RegMed Investors’ (RMi) closing bell: another moves to a sector downside
May 5, 2021
RegMed Investors’ (RMi) closing bell: the sector bounce-back was stifled by the close
May 4, 2021
RegMed Investors’ (RMi) closing bell: sector pukes most upsides
May 3, 2021
RegMed Investors’ (RMi) closing bell: new trading month starts on a down sector message from the cosmos
April 30, 2021
RegMed Investors’ (RMi) closing bell: the table was set but, when the upside was served
April 29, 2021
RegMed Investors’ (RMi) closing bell: the trend was definitely not our friend today as the upside trail got cold
April 28, 2021
RegMed Investors’ (RMi) closing bell: I thought up-downs were an exercise
April 27, 2021
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector swings low again
April 23, 2021
RegMed Investors’ (RMi) closing bell: an answer to this a.m.’s question, “what will be sustainable”?
April 22, 2021
RegMed Investors’ (RMi) closing bell: a volatile market session with the cell and gene therapy sector maintaining altitude
April 21, 2021
RegMed Investors’ (RMi) closing bell: the come-backs, a far-cry from yesterday’s sector advance/decline (A/D) line
April 20, 2021
RegMed Investors’ (RMi) closing bell: another sell-off and downer for the sector
April 19, 2021
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector suffers from arrested development
April 15, 2021
RegMed Investors’ (RMi) closing bell: sector climbs again
April 14, 2021
RegMed Investors’ (RMi) closing bell: “the sure way of gambling is getting something for nothing” after a Tuesday bounce
April 13, 2021
RegMed Investors’ (RMi) closing bell: the gain and the pain with a spike, a flame -up and a shake-off after JNJ vaccine halted
April 12, 2021
RegMed Investors’ (RMi) closing bell: it was scary, staring at the cell and gene therapy sector abyss
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2021 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.